1 - 25 of 130 results for author:"Hegele R.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (37)
| Activation of peroxisome proliferator-activated receptor delta inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein. Bojic L.A., Sawyez C.G., Telford D.E., Edwards J.Y., Hegele R.A., Huff M.W. Arterioscler. Thromb. Vasc. Biol. 32:2919-2928(2012) · Mapped (5) |
| BRCA2 variants and cardiovascular disease in a multi-ethnic study. Zbuk K., Xie C., Young R., Heydarpour M., Pare G., Davis A.D., Miller R., Lanktree M.B., Saleheen D., Danesh J. et al. BMC Med. Genet. 13:56-56(2012) · Mapped (18) |
| Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARgamma deficiency. Campeau P.M., Astapova O., Martins R., Bergeron J., Couture P., Hegele R.A., Leff T., Gagne C. J. Lipid Res. 53:1968-1978(2012) · Mapped (9) |
| Lipoprotein(a): more interesting than ever after 50 years. Dube J.B., Boffa M.B., Hegele R.A., Koschinsky M.L. Curr. Opin. Lipidol. 23:133-140(2012) · Mapped (7) |
| Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. Surendran R.P., Visser M.E., Heemelaar S., Wang J., Peter J., Defesche J.C., Kuivenhoven J.A., Hosseini M., Peterfy M., Kastelein J.J. et al. J. Intern. Med. 272:185-196(2012) · Mapped (15) |
| Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. Basel-Vanagaite L., Zevit N., Zahav A.H., Guo L., Parathath S., Pasmanik-Chor M., McIntyre A.D., Wang J., Albin-Kaplanski A., Hartman C. et al. Am. J. Hum. Genet. 90:49-60(2012) · UniProtKB (1) · Mapped (2) |
| TMEM237 is mutated in individuals with a Joubert syndrome related disorder and expands the role of the TMEM family at the ciliary transition zone. Huang L., Szymanska K., Jensen V.L., Janecke A.R., Innes A.M., Davis E.E., Frosk P., Li C., Willer J.R., Chodirker B.N. et al. Am. J. Hum. Genet. 89:713-730(2011) · UniProtKB (6) · Mapped (7) |
| HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study. Ley S.H., Hegele R.A., Harris S.B., Mamakeesick M., Cao H., Connelly P.W., Gittelsohn J., Retnakaran R., Zinman B., Hanley A.J. BMC Med. Genet. 12:1-1(2011) · Mapped (17) |
| Temtamy preaxial brachydactyly syndrome is caused by loss-of-function mutations in chondroitin synthase 1, a potential target of BMP signaling. Li Y., Laue K., Temtamy S., Aglan M., Kotan L.D., Yigit G., Canan H., Pawlik B., Nurnberg G., Wakeling E.L. et al. Am. J. Hum. Genet. 87:757-767(2010) · UniProtKB (1) · Mapped (8) |
| Increased blood pressure and hyperdynamic cardiovascular responses in carriers of a common hyperfunctional variant of adenylyl cyclase 6. Hodges G.J., Gros R., Hegele R.A., Van Uum S., Shoemaker J.K., Feldman R.D. J. Pharmacol. Exp. Ther. 335:451-457(2010) · Mapped (4) |
| Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study. Ley S.H., Hegele R.A., Connelly P.W., Harris S.B., Mamakeesick M., Cao H., Gittelsohn J., Retnakaran R., Zinman B., Hanley A.J. Cardiovasc Diabetol 9:39-39(2010) · Mapped (17) |
| Biological, clinical and population relevance of 95 loci for blood lipids. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., Pirruccello J.P., Ripatti S., Chasman D.I., Willer C.J. et al. |
| Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Johansen C.T., Wang J., Lanktree M.B., Cao H., McIntyre A.D., Ban M.R., Martins R.A., Kennedy B.A., Hassell R.G., Visser M.E. et al. Nat. Genet. 42:684-687(2010) · Mapped (28) |
| Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. Zeissig S., Dougan S.K., Barral D.C., Junker Y., Chen Z., Kaser A., Ho M., Mandel H., McIntyre A., Kennedy S.M. et al. J. Clin. Invest. 120:2889-2899(2010) · Mapped (5) |
| Genetic variation in hyaluronan metabolism loci is associated with plasma plasminogen activator inhibitor-1 concentration. Lanktree M.B., Johansen C.T., Anand S.S., Davis A.D., Miller R., Yusuf S., Hegele R.A. Blood 116:2160-2163(2010) · Mapped (21) |
| Rare ATGL haplotypes are associated with increased plasma triglyceride concentrations in the Greenland Inuit. Johansen C.T., Gallinger Z.R., Wang J., Ban M.R., Young T.K., Bjerregaard P., Hegele R.A. Int J Circumpolar Health 69:3-12(2010) · Mapped (2) |
| Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Lanktree M.B., Anand S.S., Yusuf S., Hegele R.A. Circ Cardiovasc Genet 3:39-46(2010) · Mapped (7) |
| Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? Heid I.M., Huth C., Loos R.J., Kronenberg F., Adamkova V., Anand S.S., Ardlie K., Biebermann H., Bjerregaard P., Boeing H. et al. PLoS Genet. 5:e1000694-e1000694(2009) · Mapped (2) |
| APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians. Lahiry P., Cao H., Ban M.R., Pollex R.L., Mamakeesick M., Zinman B., Harris S.B., Hanley A.J., Huff M.W., Connelly P.W. et al. J. Lipid Res. 51:843-848(2010) · Mapped (2) |
| Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. Polisecki E., Peter I., Simon J.S., Hegele R.A., Robertson M., Ford I., Shepherd J., Packard C., Jukema J.W., de Craen A.J. et al. J. Lipid Res. 51:1201-1207(2010) · Mapped (2) |
| Multi-ethnic genetic association study of carotid intima-media thickness using a targeted cardiovascular SNP microarray. Lanktree M.B., Hegele R.A., Yusuf S., Anand S.S. Stroke 40:3173-3179(2009) · Mapped (35) |
| A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Hegele R.A., Ban M.R., Hsueh N., Kennedy B.A., Cao H., Zou G.Y., Anand S., Yusuf S., Huff M.W., Wang J. Hum. Mol. Genet. 18:4189-4194(2009) · Mapped (89) |
| Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Mulvihill E.E., Allister E.M., Sutherland B.G., Telford D.E., Sawyez C.G., Edwards J.Y., Markle J.M., Hegele R.A., Huff M.W. Diabetes 58:2198-2210(2009) · Mapped (10) |
| Cystathionine gamma-lyase: Clinical, metabolic, genetic, and structural studies. Kraus J.P., Hasek J., Kozich V., Collard R., Venezia S., Janosikova B., Wang J., Stabler S.P., Allen R.H., Jakobs C. et al. Mol. Genet. Metab. 97:250-259(2009) · Mapped (3) |
| Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. Lanktree M.B., Anand S.S., Yusuf S., Hegele R.A. J. Lipid Res. 50:1487-1496(2009) · Mapped (30) |